ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,994, issued on July 7, was assigned to GENMAB A/S (Valby, Denmark).
"Humanized or chimeric CD3 antibodies" was invented by Rik Rademaker (Utrecht, Netherlands), Isil Altintas (Utrecht, Netherlands), Patrick Engelberts (Utrecht, Netherlands), Janine Schuurman (Utrecht, Netherlands) and Paul Parren (Utrecht, Netherlands).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to humanized or chimeric antibodies binding CD3. It furthermore relates to bispecific antibodies, compositions, pharmaceutical compositions, use of said antibodies in the treatment of a disease, and method of treatment."
The patent was filed on May 9, 2022, un...